Dr. Gill’s previous research focused on how acute exposure to alcohol affects attentional performance and function of the prefrontal cortex in animal models of alcohol self-administration and relapse, and during reward-seeking behaviors unrelated to drugs. To study these pathways, he incorporated viral-mediated agents that can disrupt mRNA of specific proteins or deliver opsins for optogenetic stimulation/inhibition of cellular activity. Currently, as Director of the Neurobehavioral Core, he works with investigators at Gladstone and the University of California, San Francisco (UCSF) to evaluate behavioral phenotypes in various neurodegenerative and neurological disease models. Dr. Gill earned a bachelor degree in psychology from the University of California, Irvine. He then received his doctorate in experimental psychology from the University of North Carolina at Chapel Hill, where he studied muscarinic receptors during cognitive decline in aging with Dr. Michela Gallagher. He then completed postdoctoral training with Dr. Bennet Givens at Ohio State University, where he investigated the relationship between neuronal activity in the medial prefrontal cortex and sustained visual attention, and how this relationship is modulated by cholinergic function. He also studied the effects of ethanol on attentional performance and correlated neuronal activity within the medial prefrontal cortex. He then accepted a senior scientist position working with Dr. Patricia Janak at the Ernest Gallo Clinic and Research Center in Emeryville, CA, an affiliate of UCSF. After serving as the Behavioral Core Director for the Alcohol Center grant, he joined Gladstone as a staff scientist and Director of the Neurobehavioral Core.